Good stuff as always. I believe their European partner is...

Good stuff as always. I believe their European partner is already repping a product similar to Novosorb. If and when they do decide to add a product like Novosorb to their distribution network they will need to strike a deal that has whoever they partner with helping to defray the upfront costs of educating practioners on a product they may not be familiar with. There a currently several competitors being used in the US. Young companies often get in trouble by expanding too quickly. Unlike some, I have no problem with ramping expenditures if I can see the potential growth on the back end. The growth vs expenditure in this case would be difficult to predict initially. Need to get their ducks in a row before going there IMO.